NCT00227617 2023-05-22Combination Chemotherapy and Bevacizumab in Treating Patients With Advanced Neuroendocrine TumorsUniversity of California, San FranciscoPhase 2/3 Terminated36 enrolled 14 charts
NCT00398320 2017-03-01Phase II Capecitabine, Oxaliplatin & Bevacizumab for Metastatic / Unresectable Neuroendocrine TumorsStanford UniversityPhase 2 Completed40 enrolled 9 charts
NCT00091182 2013-06-05Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentNational Cancer Institute (NCI)Phase 2 Completed180 enrolled
NCT00005860 2011-04-26Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the PeritoneumNational Cancer Institute (NCI)Phase 1 Completed